How many times have you started to have a conversation with someone about Hepatitis C only to have it blow up in your face? Have you ever heard someone say something about Hep C that didn't seem quite right to you? You were probably right something was amiss. A discussion about Hepatitis C can...
As per Wikipedia, the definition of a stigma is as follows: "Stigma is a word that originally means a "sign", "point", or "branding mark"." Wikipedia goes on to call stigma "A badge of shame, a physical mark of infamy or disgrace." Damn that w...
Recently, the CDC (Center for Disease Control) issued a statement that all Baby Boomers should be tested for Hepatitis C. The question often comes up as to why this particular segment of people is so vulnerable. What does being born between 1945 and 1965 have to do with Hepatitis C? What was di...
Buyer Beware! There are several snake oil salesmen out there who are claiming to have cured their own Hepatitis C with herbs, supplements and parking lot gravel. Okay, maybe not the parking lot gravel but it might as well be. What you need to remember is that there are two different types of...
Most every adult woman (and an occasional man) has enjoyed a manicure and a pedicure at a nail salon or spa. That 30 minute pedicure can be so relaxing but are you aware of the danger lurking in that nail salon? Although few individuals recognize the medical risks associated with this common pr...
Nairobi, Kenya — Kenya has secured over Sh136 million from the Global Fund to implement a three year pilot project where the government will provide Intravenous Drug Users (IDUs) with needles and syringes.
This is part of a Sh41 billion grant for the round 10 of the funds for HIV/AIDS, TB and Malaria approved for Kenya, the single largest approval for any country since 2002.
Global Fund Kenya Coordinating Mechanism Secretariat Coordinator Peter Cherutich said the project to be done in at the Coast and Nairobi regions aims to set up 25 pilot sites in the two regions.
"If indeed it is feasible, it's practical that we can provide needles through the exchange programmes then we will be asking for more resources from other partners to make sure that we do that and expand work on injecting drug users," Cherutich told Capital FM News.
He however said it could take three to six months to start the pilot project since the government was still in negotiation with the various partners on how to roll out the project.
"We have to engage the provincial administration, religious leaders and we have also to engage the community leaders and the political leaders so that there is an understanding that as a country we have an obligation to make sure that we protect our people from drug use but you also have an obligation to protect those who are using drugs from getting HIV," Cherutich who is also the National AIDS and STI Control Programme (NASCOP) Deputy Director said.
But, since the government expressed its intention last month to provide free needles and syringes for IDUs there has been great opposition with religious leaders saying it would promote drug use in the country.
The Christians and Muslims leaders have instead advocated for the establishment of more rehabilitation centres for drug addicts.
But the proponents of the programme argue that Intravenous Drug Users use unsafe techniques which include needle-sharing and flash blood where drug users share a syringe that has blood from another drug user to act as the drug and this increases the risk of contracting HIV/AIDS.
Meanwhile, Cherutich has admitted to underperformance in earlier years of implementation of the Global Fund.
He however said the secretariat which is responsible for coordinating, monitoring, evaluating and supporting the implementation of the grants was now dealing with the gaps which had led to slow implementation of the funds.
"The systems have improved. Right now at the country coordinating mechanism, you have to declare conflict of interest so that if you are sitting there as a member of the country coordinating mechanism, then it's very clear that that position does not create a situation where you provide undue advantage to the organisation that you lead," he said.
Kenya started receiving the funds in 2002. Between 2002 and 2010, the Global Fund approved Sh32.2 billion for Kenya out of which the country has received Sh17.5 billion.
This is because the country has been slow in implementing programmes and the Global Fund releases the grant in phases based on performance rating.
"When you apply for the money to be disbursed, sometimes the unit costs change and prices come down, so you ask for less money than you actually were approved for. So it's not that we are losing," Cherutich explained.
He also said the secretariat now had a clear understanding of how the Global Fund worked and can provide sufficient oversight.
"We have what we call a dash board. There is an allowable time from when the grant is signed to the time the Treasury gets that money and usually it is between three to six months so we have committed all of us to work within those timeframes and that is the only way we can get money flowing from Geneva to the Treasury to the Ministries of Health and eventually now to implementation," he explained.
Please sign the ATC Salvage Therapy Petition Join us in asking Congressman Alcee Hastings and Congresswomen Maxine Waters to send a ‘Dear Colleague’ letter to Anthony Fauci, Director of NIAID, asking for the federal facilitation of apricitabine (ATC). ATC is a phase III nucleoside reverse transcriptase inhibitor (NRTI) that has been shown to be safe and effective in treating people with HIV. It works against viruses that are resistant to several other nukes and could ...
Researchers from Johns Hopkins Children’s Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School announced today at CROI2013 the discovery of the first infant functionally cured of HIV. The baby, a female now two and a half years old, received 3 HIV medications when brought to the hospital at 30 hours old. Viral load tests were performed during the first few weeks that showed a rapidly decreasing viral load which reached ...
At the 19th International AIDS Conference (AIDS 2012) in Washington D.C., the CDC reported that only 1 out of 4 HIV patients in the U.S. have HIV under control, which is defined as complete viral suppression. Warning bells should be ringing in the scientific and HIV advocacy communities. While much progress has been made in the last three decades in the treatment of HIV, tens of thousands of people living with HIV (PLWH) are currently struggling to construct viable treat...
Paige Rawl is 17 and HIV positive, but while her life has been shaped by HIV it isn't ruled by it. When Paige Rawl starts her senior year at Indianapolis’s Herron High School next month, she'll be cheer captain and a member of the student government and prom committee. This summer, the 17-year-old held down a part-time job at Hollister, hawking the popular Southern California-inspired clothing brand. The all-American girl — who happens to be HIV positive. Paige was in...
The HIV community has been abuzz with the August FDA approval of what had been termed “the Quad”, the second one-pill-once-a-day combination antiretroviral drug. Marketed by Gilead under the name Stribild, the drug contains two NRTIs (tenofovir and emtricitabine), an integrase inhibitor (elvitegravir) and an integrase booster (cobicistat) and is approved for use in treatment naïve patients with either drug resistant or wild type virus. In comparison to Atripla, the first...

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for SUSTIVA® (efavirenz), including dosing recommendations for...

California and other states would be pressured to amend or repeal criminal laws that single out HIV-positive people under a bipartisan bill co-authored and introduced this week by Rep. Barbara...
Mission Statement
At HIV Haven we wish to provide our readers with vital cutting edge information to help expand HIV knowledge and promote activism, particularly that which works towards an end to the HIV pandemic. It is our desire to bring to you the scientific, medical and social advances that given the appropriate attention and support, could change the course of the HIV pandemic, lessen the devastating effects of HIV and AIDS, better the quality and quantity of life for people living with HIV and even yield an eventual end to the HIV pandemic. We also provide the basics of HIV transmission and treatment.
We will focus on issues such as innovative drug development, strategic activist campaigns, HIV relationships and novel HIV and HIV cure research. We also will bring you advances in Hepatitis C (HCV), a common HIV co-infection. Whether you are living with HIV/AIDS, HIV and HCV, love someone who is, are an activist, advocate, researcher, physician or just an interested party, we hope here at HIV Haven we can help you find what you are looking for.